Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

15d-PGJ2-loaded nanocapsules ameliorate experimental gout arthritis by reducing pain and inflammation in a PPAR-gamma-sensitive manner in mice
Kenji W. Ruiz-Miyazawa, Larissa Staurengo‐Ferrari, Felipe A. Pinho‐Ribeiro, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

Polyunsaturated Fatty Acids: Conversion to Lipid Mediators, Roles in Inflammatory Diseases and Dietary Sources
John L. Harwood
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 8838-8838
Open Access | Times Cited: 50
Contribution of Nrf2 Modulation to the Mechanism of Action of Analgesic and Anti-inflammatory Drugs in Pre-clinical and Clinical Stages
Larissa Staurengo‐Ferrari, Stephanie Badaro‐Garcia, M. Hohmann, et al.
Frontiers in Pharmacology (2019) Vol. 9
Open Access | Times Cited: 106
15-Deoxy-∆-12,14-Prostaglandin J2 (15d-PGJ2), an Endogenous Ligand of PPAR-γ: Function and Mechanism
Jingjing Li, Chuanyong Guo, Jianye Wu
PPAR Research (2019) Vol. 2019, pp. 1-10
Open Access | Times Cited: 87
Peroxisome Proliferator-Activated Receptors as a Therapeutic Target in Asthma
O. Yu. Kytikovа, Juliy M. Perelman, Т. П. Новгородцева, et al.
PPAR Research (2020) Vol. 2020, pp. 1-18
Open Access | Times Cited: 54
The role of interleukin-1 family members in hyperuricemia and gout
Viola Klück, Ruiqi Liu, Leo A. B. Joosten
Joint Bone Spine (2020) Vol. 88, Iss. 2, pp. 105092-105092
Open Access | Times Cited: 54
RvD1 disrupts nociceptor neuron and macrophage activation and neuroimmune communication, reducing pain and inflammation in gouty arthritis in mice
Tiago H. Zaninelli, Victor Fattori, Telma Saraiva‐Santos, et al.
British Journal of Pharmacology (2022) Vol. 179, Iss. 18, pp. 4500-4515
Closed Access | Times Cited: 29
Integration of metabolomics and transcriptomics to reveal the mechanism of Gerberae piloselloidis herba in alleviating bronchial asthma
Chunhua Liu, Changli Fu, Yuan Lü, et al.
Journal of Ethnopharmacology (2024) Vol. 325, pp. 117852-117852
Closed Access | Times Cited: 5
Cistanches alleviates sevoflurane‐induced cognitive dysfunction by regulating PPAR‐γ‐dependent antioxidant and anti‐inflammatory in rats
Sheng Peng, Pengyi Li, Peirong Liu, et al.
Journal of Cellular and Molecular Medicine (2019) Vol. 24, Iss. 2, pp. 1345-1359
Open Access | Times Cited: 42
The chemistry, biology and pharmacology of the cyclopentenone prostaglandins
Sumner Burstein
Prostaglandins & Other Lipid Mediators (2020) Vol. 148, pp. 106408-106408
Closed Access | Times Cited: 33
Polydatin ameliorates inflammation and oxidative stress associated with MSU-induced gouty arthritis in mice by regulating PPAR-γ and ferritin activation
Kang Du, Qun Zhou, Ziwen Wang, et al.
Life Sciences (2023) Vol. 326, pp. 121766-121766
Closed Access | Times Cited: 12
Soluble epoxide hydrolase inhibitor, TPPU, increases regulatory T cells pathway in an arthritis model
Carlos Antônio Trindade‐da‐Silva, Juliana Trindade Clemente‐Napimoga, Henrique Ballassini Abdalla, et al.
The FASEB Journal (2020) Vol. 34, Iss. 7, pp. 9074-9086
Open Access | Times Cited: 26
Role of T cells in the pathogenesis and treatment of gout
Bin Wang, Shiju Chen, Hongyan Qian, et al.
International Immunopharmacology (2020) Vol. 88, pp. 106877-106877
Closed Access | Times Cited: 26
The roles of small‐molecule inflammatory mediators in rheumatoid arthritis
Qi Cheng, Huaxiang Wu, Yan Du
Scandinavian Journal of Immunology (2020) Vol. 93, Iss. 3
Open Access | Times Cited: 25
Sirt1 inhibits gouty arthritis via activating PPARγ
Juan Wang, Guangliang Chen, Liangjing Lu, et al.
Clinical Rheumatology (2019) Vol. 38, Iss. 11, pp. 3235-3242
Closed Access | Times Cited: 24
The PPARγ agonist pioglitazone produces a female-predominant inhibition of hyperalgesia associated with surgical incision, peripheral nerve injury, and painful diabetic neuropathy
Diogo Francisco da Silva dos Santos, Renée R. Donahue, Don E. Laird, et al.
Neuropharmacology (2021) Vol. 205, pp. 108907-108907
Open Access | Times Cited: 20
Harnessing Inflammation Resolution in Arthritis: Current Understanding of Specialized Pro-resolving Lipid Mediators’ Contribution to Arthritis Physiopathology and Future Perspectives
Tiago H. Zaninelli, Victor Fattori, Waldiceu A. Verri
Frontiers in Physiology (2021) Vol. 12
Open Access | Times Cited: 18
An updated review for hyperuricemia and gout management; special focus on the available drug delivery systems and clinical trials
Ioannis D. Karantas, Αndroulla N. Miliotou, Panoraia I. Siafaka
Current Medicinal Chemistry (2023) Vol. 31, Iss. 36, pp. 5856-5883
Closed Access | Times Cited: 7
PPARγ in Ischemia-Reperfusion Injury: Overview of the Biology and Therapy
Ruizhen Huang, Chiyu Zhang, Xing Wang, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 16
The Inhibition of Phosphoinositide-3 Kinases Induce Resolution of Inflammation in a Gout Model
Izabela Galvão, Celso Martins Queiroz‐Junior, Vívian Louise Soares de Oliveira, et al.
Frontiers in Pharmacology (2019) Vol. 9
Open Access | Times Cited: 19
PPAR γ Prevents Neuropathic Pain by Down-Regulating CX3CR1 and Attenuating M1 Activation of Microglia in the Spinal Cord of Rats Using a Sciatic Chronic Constriction Injury Model
Xilei Li, Qulian Guo, Zhi Ye, et al.
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 15
Regular swimming exercise prevented the acute and persistent mechanical muscle hyperalgesia by modulation of macrophages phenotypes and inflammatory cytokines via PPARγ receptors
Graciana de Azambuja, Carolina Ocanha Jorge, Beatriz Botasso Gomes, et al.
Brain Behavior and Immunity (2021) Vol. 95, pp. 462-476
Closed Access | Times Cited: 15
Influence of Pinealectomy and Long-term Melatonin Administration on Inflammation and Oxidative Stress in Experimental Gouty Arthritis
Arwa Fadıl Haqi Ballur, Eyüp Altınöz, Gürkan Yiğittürk, et al.
Inflammation (2022) Vol. 45, Iss. 3, pp. 1332-1347
Open Access | Times Cited: 10
New drug targets for the treatment of gout arthritis: what’s new?
Tiago H. Zaninelli, Geovana Martelossi-Cebinelli, Telma Saraiva‐Santos, et al.
Expert Opinion on Therapeutic Targets (2023) Vol. 27, Iss. 8, pp. 679-703
Closed Access | Times Cited: 5
Poloxamer micellar system for intra-articular injection of 15-deoxy-Δ12,14-prostaglandin J2 with improved bioavailability and anti-inflammatory properties in the temporomandibular joint of rats
Henrique Ballassini Abdalla, Marcelo Henrique Napimoga, Cristina Gomes de Macedo, et al.
International Journal of Pharmaceutics (2020) Vol. 583, pp. 119383-119383
Open Access | Times Cited: 13
Calycosin represses AIM2 inflammasome‐mediated inflammation and pyroptosis to attenuate monosodium urate‐induced gouty arthritis through NF‐κB and p62‐Keap1 pathways
Jing Tian, Dapeng Zhou, Liangbi Xiang, et al.
Drug Development Research (2022) Vol. 83, Iss. 7, pp. 1654-1672
Closed Access | Times Cited: 8
Page 1 - Next Page

Scroll to top